GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 788 filers reported holding GLAXOSMITHKLINE PLC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $531,000 | 0.0% | 11,311 | 0.0% | 0.04% | -37.3% |
| Q4 2019 | $531,000 | +63.9% | 11,311 | +42.2% | 0.07% | +21.8% |
| Q3 2019 | $324,000 | +1.6% | 7,952 | -0.1% | 0.06% | +1.9% |
| Q2 2019 | $319,000 | -4.5% | 7,962 | -0.4% | 0.05% | -1.8% |
| Q1 2019 | $334,000 | -33.3% | 7,992 | -39.1% | 0.06% | -41.5% |
| Q4 2018 | $501,000 | -35.4% | 13,127 | -32.0% | 0.09% | -28.2% |
| Q3 2018 | $776,000 | -7.5% | 19,310 | -7.2% | 0.13% | -7.7% |
| Q2 2018 | $839,000 | -2.0% | 20,807 | -5.0% | 0.14% | -2.7% |
| Q1 2018 | $856,000 | +12.6% | 21,909 | +2.3% | 0.15% | +10.6% |
| Q4 2017 | $760,000 | -88.9% | 21,421 | -87.3% | 0.13% | -89.3% |
| Q3 2017 | $6,846,000 | -6.5% | 168,624 | -0.4% | 1.24% | -11.0% |
| Q2 2017 | $7,321,000 | +7.7% | 169,223 | +5.8% | 1.39% | +6.9% |
| Q1 2017 | $6,797,000 | +13.5% | 160,017 | +2.9% | 1.30% | +6.7% |
| Q4 2016 | $5,987,000 | -10.5% | 155,488 | -0.3% | 1.22% | -13.4% |
| Q3 2016 | $6,693,000 | +4.6% | 156,017 | +3.5% | 1.41% | +0.7% |
| Q2 2016 | $6,400,000 | +5.9% | 150,730 | +1.5% | 1.40% | +7.0% |
| Q1 2016 | $6,045,000 | +0.3% | 148,538 | +1.1% | 1.31% | -5.8% |
| Q4 2015 | $6,028,000 | +13.8% | 146,882 | +4.1% | 1.39% | +6.9% |
| Q3 2015 | $5,299,000 | -11.6% | 141,083 | -1.1% | 1.30% | -0.4% |
| Q2 2015 | $5,995,000 | +6.9% | 142,645 | +20.0% | 1.30% | +4.5% |
| Q1 2015 | $5,610,000 | +97.0% | 118,836 | +78.6% | 1.24% | +111.0% |
| Q4 2014 | $2,847,000 | -43.9% | 66,547 | -39.3% | 0.59% | -46.4% |
| Q3 2014 | $5,074,000 | -12.2% | 109,629 | +2.0% | 1.10% | -13.9% |
| Q2 2014 | $5,778,000 | +5.2% | 107,432 | +5.4% | 1.28% | +13.0% |
| Q1 2014 | $5,494,000 | +0.5% | 101,925 | -0.9% | 1.13% | +7.5% |
| Q4 2013 | $5,464,000 | +14.3% | 102,865 | +8.6% | 1.05% | +2.1% |
| Q3 2013 | $4,780,000 | – | 94,691 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |